Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion type Assertion NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_head.
- NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
- NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion evidence source_evidence_literature NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
- NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion SIO_000772 21288594 NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
- NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion wasDerivedFrom befree-20140225 NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
- NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion wasGeneratedBy ECO_0000203 NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.